Court Upholds Pfizer Patent For Norvasc
Pfizer, deflecting challenges from several generic drug makers over the patents for its second best-selling drug Norvasc, has prevailed in one of the cases, with a judge blocking an attempt by...To view the full article, register now.
Already a subscriber? Click here to view full article